313 related articles for article (PubMed ID: 38732254)
21. Therapeutic applications of nucleic acids and their analogues in Toll-like receptor signaling.
Gosu V; Basith S; Kwon OP; Choi S
Molecules; 2012 Nov; 17(11):13503-29. PubMed ID: 23151919
[TBL] [Abstract][Full Text] [Related]
22. Direct and indirect role of Toll-like receptors in T cell mediated immunity.
Xu D; Liu H; Komai-Koma M
Cell Mol Immunol; 2004 Aug; 1(4):239-46. PubMed ID: 16225766
[TBL] [Abstract][Full Text] [Related]
23. Recent patents in Toll-like receptor pathways and relevance to cancer.
Kimbro K; Parker S
Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):189-95. PubMed ID: 19522696
[TBL] [Abstract][Full Text] [Related]
24. [Responses with participation of toll-like receptors in protective immunity and in pathologic states].
Skivka LM; Pozur VV
Ukr Biokhim Zh (1999); 2008; 80(3):5-20. PubMed ID: 18959023
[TBL] [Abstract][Full Text] [Related]
25. Innate immunity and cancer therapy.
Maruyama K; Selmani Z; Ishii H; Yamaguchi K
Int Immunopharmacol; 2011 Mar; 11(3):350-7. PubMed ID: 20955832
[TBL] [Abstract][Full Text] [Related]
26. Toll-like receptors: The role in bladder cancer development, progression and immunotherapy.
Ohadian Moghadam S; Nowroozi MR
Scand J Immunol; 2019 Dec; 90(6):e12818. PubMed ID: 31448424
[TBL] [Abstract][Full Text] [Related]
27. Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity.
Duan T; Du Y; Xing C; Wang HY; Wang RF
Front Immunol; 2022; 13():812774. PubMed ID: 35309296
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor function and signaling.
Kaisho T; Akira S
J Allergy Clin Immunol; 2006 May; 117(5):979-87; quiz 988. PubMed ID: 16675322
[TBL] [Abstract][Full Text] [Related]
29. Contribution of T- and B-cell intrinsic toll-like receptors to the adaptive immune response in viral infectious diseases.
Zhang E; Ma Z; Lu M
Cell Mol Life Sci; 2022 Oct; 79(11):547. PubMed ID: 36224474
[TBL] [Abstract][Full Text] [Related]
30. The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies.
Martinsen JT; Gunst JD; Højen JF; Tolstrup M; Søgaard OS
Front Immunol; 2020; 11():1112. PubMed ID: 32595636
[TBL] [Abstract][Full Text] [Related]
31. Modulation of toll-like receptors by insulin.
Tilich M; Arora RR
Am J Ther; 2011 Sep; 18(5):e130-7. PubMed ID: 21326087
[TBL] [Abstract][Full Text] [Related]
32. Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy.
Chakraborty S; Ye J; Wang H; Sun M; Zhang Y; Sang X; Zhuang Z
Front Immunol; 2023; 14():1227833. PubMed ID: 37936697
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptors: cost or benefit for cancer?
Matijevic T; Pavelic J
Curr Pharm Des; 2010; 16(9):1081-90. PubMed ID: 20030618
[TBL] [Abstract][Full Text] [Related]
34. Novel therapeutic strategies based on toll-like receptor signaling.
Lawton JA; Ghosh P
Curr Opin Chem Biol; 2003 Aug; 7(4):446-51. PubMed ID: 12941417
[TBL] [Abstract][Full Text] [Related]
35. Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.
Ofodile ON
J Ind Microbiol Biotechnol; 2007 Dec; 34(12):751-62. PubMed ID: 17876621
[TBL] [Abstract][Full Text] [Related]
36. Toll-Like Receptors (TLRs) in the Tumor Microenvironment (TME): A Dragon-Like Weapon in a Non-fantasy Game of Thrones.
Angrini M; Varthaman A; Cremer I
Adv Exp Med Biol; 2020; 1263():145-173. PubMed ID: 32588327
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases.
Patra MC; Shah M; Choi S
Semin Cancer Biol; 2020 Aug; 64():61-82. PubMed ID: 31054927
[TBL] [Abstract][Full Text] [Related]
38. Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity.
van Egmond M; Vidarsson G; Bakema JE
Immunol Rev; 2015 Nov; 268(1):311-27. PubMed ID: 26497530
[TBL] [Abstract][Full Text] [Related]
39. The role of protein-protein interactions in Toll-like receptor function.
Berglund NA; Kargas V; Ortiz-Suarez ML; Bond PJ
Prog Biophys Mol Biol; 2015 Oct; 119(1):72-83. PubMed ID: 26144017
[TBL] [Abstract][Full Text] [Related]
40. Advances in Toll-like receptor biology: Modes of activation by diverse stimuli.
Bryant CE; Gay NJ; Heymans S; Sacre S; Schaefer L; Midwood KS
Crit Rev Biochem Mol Biol; 2015; 50(5):359-79. PubMed ID: 25857820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
